PROLYMPHOCYTIC LEUKEMIA
Clinical trials for PROLYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PROLYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for PROLYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested for Tough-to-Treat blood cancers
Disease control OngoingThis study tested a new oral medication called acalabrutinib for adults with chronic lymphocytic leukemia (CLL) and related blood cancers that had returned or stopped responding to prior treatments. The main goals were to find a safe dose and see if the drug could shrink the canc…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New strategy aims to tame dangerous virus after cancer transplant
Disease control OngoingThis study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Cancer trial tests drug combo to keep leukemia at bay
Disease control OngoingThis study aims to find out if adding the immunotherapy drug rituximab to the cancer drug ibrutinib works better than ibrutinib alone for adults whose chronic lymphocytic leukemia has returned after prior treatment. It will compare how long patients stay cancer-free on each regim…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC